Efficacy and safety of long-acting injectable oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis

• Main Authors: Giovanni Vita (Author), Angelantonio Tavella (Author), Giovanni Ostuzzi (Author), Federico Tedeschi (Author), Michele De Prisco (Author), Rafael Segarra (Author), Marco Solmi (Author), Corrado Barbui (Author), Christoph U. Correll (Author)
• Formato: Libro
• Publicado: SAGE Publishing, 2024-06-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Background: Long-acting injectable antipsychotics (LAIs) have advantages over oral antipsychotics (OAPs) in preventing relapse and hospitalization in chronically ill patients with schizophrenia-spectrum disorders (SSDs), but evidence in patients with first-episode/recent-onset, that is, early-phase-...